Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
ALMS
ALMS
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
ALMS News
Wall Street Analysts Adjust Ratings
Feb 26 2026
Benzinga
Wall Street Analysts Adjust Ratings
Feb 25 2026
Benzinga
Wall Street Analysts Adjust Ratings
Feb 25 2026
Benzinga
BML Capital Management Fully Exits Alumis Stake
Feb 03 2026
Fool
Brookfield to Acquire Peakstone Realty Trust for $1.2 Billion
Feb 02 2026
Benzinga
Analysts Bullish on Century Communities, Target Price Set at $92
Jan 21 2026
Benzinga
Alumis Director Srinivas Akkaraju Purchases 588,235 Shares for ~$10 Million
Jan 17 2026
Fool
Alumis (NASDAQ:ALMS) Acquires 588,235 Shares for $10 Million
Jan 17 2026
NASDAQ.COM
Activist Investors Target Staar Surgical, Alumis, and Other Stocks
Jan 17 2026
Barron's
Russell 2000 Kicks Off 2026 Strong, Surging Over 7% Year-to-Date
Jan 15 2026
Benzinga
Alumis Inc. (ALMS) Reports 65% PASI 90 Achievement for Envudeucitinib in Psoriasis Trials
Jan 14 2026
NASDAQ.COM
Alumis Inc. Closes $345.1 Million Upsized Public Offering
Jan 09 2026
Globenewswire
Alumis Inc. Prices 17.65M Shares at $17 Each, Raising Approximately $300M
Jan 08 2026
Benzinga
Alumis Inc. Prices Upsized Public Offering of 17.65 Million Shares, Raising Approximately $300 Million
Jan 08 2026
Globenewswire
SanDisk Shares Surge 27.56% to $349.63 Amid Positive Market Sentiment
Jan 07 2026
Benzinga
Alumis Surges 95.31% on Phase 3 Psoriasis Data, Plans $175M Offering
Jan 06 2026
Fool
Show More News
